Podcast

Rheumatology Biologics Registries

This podcast discusses the importance of clinical rheumatology biologics registries.

In the latest installment in the podcast series created by the journal Rheumatology, Robert Moots and David Isenberg “discuss registries, what they are, their aims and outcomes,” highlighting the British Society for Rheumatology Biologics Register (the largest biologics register in the world,) “detailing its design, aims and findings.” This podcast was produced in conjunction with the journal’s “themed issue on Registries in Rheumatological and Musculoskeletal Conditions.”

Click here to access this third-party podcast resource.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.